Clinical Trials for Lipoprotein(a)
Research and understanding of elevated lipoprotein(a) is growing. Clinical trials, sometimes referred to as interventional studies, test new treatments or new combinations of treatments. Clinical trials help researchers evaluate the safety and effectiveness of therapies to improve the quality of care for affected individuals.
Why participate in Lipoprotein(a) clinical research?
By participating in clinical research, you will play an active role in your own healthcare and contribute to the greater good. Because Familial Lipoprotein(a) is a family disorder, clinical research offers hope and the opportunity to have a powerful impact on the lives of your family members and your future generations.
The Lp(a) Association seeks to (1) encourage the patient community to step forward and participate in Familial Lipoprotein(a) research and (2) add to the current body of knowledge about this condition.
Observational studies are one type of clinical trial. There are no treatments or actions in an observational study. This type of study can help inform how to best diagnose, treat, and manage a disease or a condition.